Skip to Content
Merck

Skip To

M7068

MPP dihydrochloride hydrate

≥97% (HPLC), powder, estrogen receptor α agonist

Synonym(s):

1,3-Bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride hydrate, Methyl-piperidino-pyrazole hydrate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice
10 mg
Check Cart for Availability
MXP 5,599.00
25 mg
Check Cart for Availability
MXP 9,378.00
MXP 7,971.30

About This Item

Empirical Formula (Hill Notation):
C29H31N3O3 · 2 HCl · xH2O
CAS Number:
Molecular Weight:
542.50 (anhydrous basis)
UNSPSC Code:
51111800
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥97% (HPLC)
Form:
powder
Quality level:
Storage condition:
desiccated

MXP 5,599.00


Check Cart for Availability

Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

MPP dihydrochloride hydrate, ≥97% (HPLC), white, powder

Quality Level

assay

≥97% (HPLC)

form

powder

storage condition

desiccated

color

white

solubility

DMSO: soluble ≥20 mg/mL

SMILES string

Cl.Cl.Cc1c(nn(-c2ccc(O)cc2)c1-c3ccc(OCCN4CCCCC4)cc3)-c5ccc(O)cc5

InChI

1S/C29H31N3O3.2ClH/c1-21-28(22-5-11-25(33)12-6-22)30-32(24-9-13-26(34)14-10-24)29(21)23-7-15-27(16-8-23)35-20-19-31-17-3-2-4-18-31;;/h5-16,33-34H,2-4,17-20H2,1H3;2*1H

InChI key

FWDNPWVVRVSJQH-UHFFFAOYSA-N

General description

Methyl-piperidino-pyrazole hydrate (MPP) is prepared from a methyl-pyrazole-triol (MPT), a pyrazole triol.[1]

Application

MPP dihydrochloride hydrate has been used as an estrogen receptor α antagonist:
  • in human breast cancer MCF-7 cells[2]
  • to pre-treat endometrial ex vivo organ cultures (EVOCs)[3]
  • to treat pituitary glands to monitor luteinizing hormone secretion[4]

Biochem/physiol Actions

MPP dihydrochloride is a specific estrogen receptor α antagonist.
Methyl-piperidino-pyrazole hydrate (MPP) is an agonist for estrogen receptor α and lacks any ligand functionality with estrogen receptor (ER)β.[1] It promotes silibinin induced apoptosis in human breast cancer MCF-7 cells.[2]
Specific estrogen receptor α antagonist.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
PZ0159G5793PZ0136
assay

≥97% (HPLC)

assay

>98% (HPLC)

assay

>98% (HPLC)

assay

≥97% (HPLC)

form

powder

form

powder

form

powder

form

solid

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

solubility

DMSO: soluble ≥20 mg/mL

solubility

H2O: ≥13 mg/mL

solubility

DMSO: 10 mg/mL, clear

solubility

H2O: ≥5 mg/mL

storage condition

desiccated

storage condition

desiccated

storage condition

desiccated

storage condition

-

color

white

color

white to tan

color

white to beige

color

white to off-white


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Fu Guangtao et al.
Frontiers in pharmacology, 12, 746391-746391 (2021-11-23)
Periprosthetic osteolysis is one of the major long-term complications following total joint replacement. Its cause is widely accepted to be wear particle-induced activation of inflammatory macrophages. No effective strategy for the prevention and treatment of periprosthetic osteolysis is yet available.
Nan Zheng et al.
Journal of pharmacological sciences, 128(3), 97-107 (2015-06-29)
The estrogen receptor alpha (ERα) has been proven to be one of the most important therapeutic targets in breast cancer over the last 30 years. Previous studies pointed out that a natural flavonoid, silibinin, induced apoptosis in human breast cancer
João P E Saut et al.
Reproduction (Cambridge, England), 148(6), 593-606 (2014-09-24)
The risk of bacterial infection of the endometrium causing uterine disease in cattle is increased in the progesterone-dominated luteal phase of the ovarian cycle, while oestrogens or oestrus are therapeutic or protective against disease. The first line of defence against



Global Trade Item Number

SKUGTIN
M7068-10MG04061834061595
M7068-25MG04061833272930

Questions

Reviews

No rating value

Active Filters